簡介

本頁面提供了有關 Jon Snodgres 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Jon Snodgres已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:RGEN / Repligen Corporation Chief Financial Officer 37,381
如何解讀這些圖表

以下圖表顯示了在Jon Snodgres進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Jon Snodgres 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2023-05-16 2023-05-16 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -710 37,381 -1.86 154.03 -109,361 5,757,795
2023-03-06 2023-03-03 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -3,674 38,091 -8.80 188.00 -690,712 7,161,108
2023-03-06 2023-03-03 4 RGEN REPLIGEN CORP
Common Stock
A - Award 8,795 41,765 26.68
2023-03-06 2023-03-02 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,848 32,970 17.24
2023-03-01 2023-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -521 28,122 -1.82 173.28 -90,279 4,872,980
2023-02-28 2023-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -682 28,643 -2.33 173.44 -118,286 4,967,842
2023-02-17 2023-02-16 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -5,647 29,325 -16.15 200.00 -1,129,400 5,865,000
2022-10-11 2022-10-07 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise X 466 34,972 1.35 59.52 27,736 2,081,533
2022-08-17 2022-08-16 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -2,400 34,506 -6.50 253.16 -607,584 8,735,539
2022-08-17 2022-08-16 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -4,298 36,906 -10.43 252.70 -1,086,105 9,326,146
2022-08-17 2022-08-16 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 970 41,204 2.41 215.58 209,113 8,882,758
2022-08-17 2022-08-16 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 3,047 40,234 8.19 86.10 262,347 3,464,147
2022-08-02 2022-08-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2,000 37,187 -5.10 220.00 -440,000 8,181,140
2022-05-17 2022-05-13 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -712 39,187 -1.78 150.40 -107,085 5,893,725
2022-03-09 2022-03-08 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 1,214 2,574 89.26
2022-03-09 2022-03-08 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 2,952 13,707 27.45
2022-03-09 2022-03-08 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 1,214 39,899 3.14 59.52 72,257 2,374,788
2022-03-09 2022-03-08 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,952 38,685 8.26 33.87 99,984 1,310,261
2022-03-02 2022-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -2,468 35,733 -6.46 196.70 -485,456 7,028,681
2022-03-02 2022-02-28 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,922 38,201 18.35
2022-03-02 2022-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -661 32,279 -2.01 196.70 -130,019 6,349,279
2022-03-02 2022-02-27 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -695 32,940 -2.07 196.70 -136,706 6,479,298
2022-02-28 2022-02-24 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 4,410 4,410
2022-02-28 2022-02-24 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -269 33,635 -0.79 189.21 -50,897 6,364,078
2022-02-28 2022-02-24 4 RGEN REPLIGEN CORP
Common Stock
A - Award 3,443 33,904 11.30
2022-02-22 2022-02-17 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -332 30,461 -1.08 182.42 -60,563 5,556,696
2022-02-22 2022-02-17 4 RGEN REPLIGEN CORP
Common Stock
A - Award 900 30,793 3.01
2021-05-18 2021-05-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -470 31,893 -1.45 172.60 -81,122 5,504,732
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -600 32,363 -1.82 189.75 -113,850 6,140,879
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -603 32,963 -1.80 190.45 -114,841 6,277,803
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -500 33,566 -1.47 191.43 -95,715 6,425,539
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -900 34,066 -2.57 192.54 -173,286 6,559,068
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -242 34,966 -0.69 193.72 -46,880 6,773,614
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -500 35,208 -1.40 196.30 -98,150 6,911,330
2021-03-08 2021-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -200 35,708 -0.56 197.86 -39,572 7,065,185
2021-02-26 2021-02-24 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 2,910 2,910
2021-02-26 2021-02-24 4 RGEN REPLIGEN CORP
Common Stock
A - Award 2,410 35,908 7.19
2021-01-26 2021-01-25 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -4,000 6,887 -36.74
2021-01-26 2021-01-25 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 4,000 33,498 13.56 33.87 135,480 1,134,577
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -59 29,498 -0.20 195.77 -11,550 5,774,823
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -571 29,557 -1.90 195.16 -111,436 5,768,344
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -218 30,128 -0.72 193.88 -42,266 5,841,217
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -918 30,346 -2.94 192.74 -176,935 5,848,888
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -202 31,264 -0.64 190.50 -38,481 5,955,792
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1,333 31,466 -4.06 190.09 -253,390 5,981,372
2021-01-06 2021-01-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -656 32,799 -1.96 188.69 -123,781 6,188,843
2020-11-10 2020-11-10 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -3,086 0 -100.00
2020-11-10 2020-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -3,086 33,455 -8.45 193.00 -595,598 6,456,815
2020-11-10 2020-11-10 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 3,086 36,541 9.22 32.40 99,986 1,183,928
2020-11-10 2020-11-09 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -1,893 3,788 -33.32
2020-11-10 2020-11-09 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 1,893 33,455 6.00 59.52 112,671 1,991,242
2020-11-10 2020-11-09 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -705 31,562 -2.18 194.69 -137,256 6,144,806
2020-05-19 2020-05-15 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -660 32,267 -2.00 140.43 -92,684 4,531,255
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -9,024 3,086 -74.52
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -3,170 0 -100.00
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -846 32,927 -2.50 132.37 -111,985 4,358,547
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -3,013 33,773 -8.19 131.38 -395,848 4,437,097
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,700 36,786 -4.42 130.20 -221,340 4,789,537
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,612 38,486 -4.02 128.70 -207,464 4,953,148
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -2,865 40,098 -6.67 127.75 -366,004 5,122,520
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -5,358 42,963 -11.09 126.77 -679,234 5,446,420
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 9,024 48,321 22.96 32.40 292,378 1,565,600
2020-05-15 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 3,170 39,297 8.77 26.05 82,578 1,023,687
2020-03-05 2020-03-04 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,045 36,127 -2.81 90.39 -94,458 3,265,520
2020-03-05 2020-03-03 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -610 37,172 -1.61 88.18 -53,790 3,277,827
2020-03-02 2020-02-27 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award -4,571 4,571 -50.00
2020-03-02 2020-02-27 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,686 37,782 14.16
2020-02-27 2020-02-26 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -946 31,096 -2.95 86.11 -81,460 2,677,677
2020-02-27 2020-02-26 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -154 32,042 -0.48 86.86 -13,376 2,783,168
2019-12-09 2019-12-05 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -1,957 3,170 -38.17
2019-12-09 2019-12-05 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -2,000 0 -100.00
2019-12-09 2019-12-05 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 1,957 32,196 6.47 26.05 50,980 838,706
2019-12-09 2019-12-05 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,000 30,239 7.08 24.50 49,000 740,856
2019-07-17 2019-07-15 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -295 28,239 -1.03 85.95 -25,355 2,427,142
2019-06-11 2019-02-28 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 5,681 5,681
2019-05-15 2019-05-13 4 RGEN REPLIGEN CORP
Common Stock
A - Award 8,000 28,534 38.96
2019-03-27 2019-03-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1,009 20,534 -4.68 59.05 -59,581 1,212,533
2019-03-27 2019-03-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -5,458 21,543 -20.21 58.45 -319,020 1,259,188
2019-03-05 2019-03-05 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -2,645 27,001 -8.92 58.52 -154,785 1,580,099
2019-03-05 2019-03-01 4 RGEN REPLIGEN CORP
Common Stock
A - Award 4,700 29,646 18.84
2019-03-04 2019-02-28 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 5,653 5,653
2019-03-04 2019-02-28 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,875 24,946 -6.99 58.88 -110,400 1,468,820
2019-03-04 2019-02-28 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,922 26,821 28.34
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -10,253 5,127 -66.66
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -6,055 12,110 -33.33
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -4,000 2,000 -66.67
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -11,445 0 -100.00
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -31,753 20,899 -60.31 63.49 -2,015,915 1,326,823
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 10,253 52,652 24.18 26.05 267,091 1,371,585
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 6,055 42,399 16.66 32.40 196,182 1,373,728
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 4,000 36,344 12.37 24.50 98,000 890,428
2018-11-28 2018-11-26 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 11,445 32,344 54.76 26.20 299,859 847,413
2018-08-29 2018-08-28 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -14,460 20,899 -40.89 52.79 -763,359 1,103,281
2018-07-20 2018-07-18 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -295 35,359 -0.83 47.91 -14,134 1,694,085
2018-03-05 2018-03-01 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 20,659 20,659
2018-03-05 2018-03-01 4 RGEN REPLIGEN CORP
Common Stock
A - Award 10,680 35,654 42.76
2018-03-02 2018-02-28 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -2,470 24,974 -9.00 35.16 -86,843 878,061
2017-07-20 2017-07-18 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -345 27,444 -1.24 41.77 -14,411 1,146,336
2017-05-22 2017-02-23 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 18,165 18,165
2017-03-21 2017-03-17 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -4,000 6,000 -40.00
2017-03-21 2017-03-17 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 4,000 27,789 16.81 24.50 98,000 680,830
2017-03-21 2017-03-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,909 23,789 -7.43 34.91 -66,646 830,510
2017-03-21 2017-02-23 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 19,750 19,750
2017-03-01 2017-03-01 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -1,630 25,698 -5.96 32.07 -52,273 824,117
2017-03-01 2017-02-23 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 19,750 19,750
2017-03-01 2017-02-23 4 RGEN REPLIGEN CORP
Common Stock
A - Award 9,875 27,328 56.58
2016-07-15 2016-07-14 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -324 17,453 -1.82 26.56 -8,605 463,552
2016-03-01 2016-02-29 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -748 17,777 -4.04 26.05 -19,485 463,091
2016-03-01 2016-02-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 15,380 15,380
2016-03-01 2016-02-26 4 RGEN REPLIGEN CORP
Common Stock
A - Award 7,905 18,525 74.44
2015-11-12 2015-07-14 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -325 10,620 -2.97 41.30 -13,422 438,606
2015-03-02 2015-02-26 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 11,445 11,445
2015-03-02 2015-02-26 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,945 10,945 118.90
2014-07-15 2014-07-14 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 10,000 10,000
2014-07-15 2014-07-14 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,000 5,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)